Drug Store News

U.S. District Court rules in favor of Merck in sitagliptin phosphate patent lawsuit

The U.S. District Court for the Northern District of West Virginia has ruled in favor of Merck in a patent infringement suit against Viatris related to sitagliptin, an active ingredient in Januvia, ...
JD Supra

Merck’s JANUVIA crystalline monohydrate DHP salt patent found valid

In a patent infringement action brought under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations, in relation to sitagliptin phosphate monohydrate (Merck’s JANUVIA), Justice ...
Medscape

Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin for Patients With Type 2 Diabetes Mellitus

Janumet™ (MK-0431A) combines two OADs with complementary mechanisms of action to improve glycemic control, sitagliptin and metformin. The tablet was designed in order to be bioequivalent to ...
JD Supra

New ANDA Cases - Spring 2019

Valeant Pharms. North America LLC v. Zydus Pharms. (USA) Inc., 19-5162 (D.N.J.) Feb. 8, 2019 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution ...
CBS News

FDA Approves New Diabetes Drug

Diabetics gained a new way of controlling their blood sugar levels Tuesday with federal approval of a novel pill for Type 2 diabetes, which affects about 20 million Americans. The Food and Drug ...
PharmaTimes

Merck’s Januvia first for US review

The US Food and Drug Administration has agreed to review Merck & Co’s application to market its experimental diabetes drug, Januvia (sitagliptin phosphate), placing the firm ahead of the pack in the ...
FiercePharma

In a New Study, Treatment With JANUMET® (sitagliptin/metformin), Merck's Diabetes Medicine, Resulted In Significantl

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- New data were presented at the American Diabetes Association (ADA) 70 th Annual Scientific Sessions from a study comparing ...
Monthly Prescribing Reference

Brynovin, an Oral Liquid Formulation of Sitagliptin, Now Available

The oral solution is supplied in a 120mL bottle containing 25mg of sitagliptin per mL. Brynovin ™, an oral solution formulation of sitagliptin, is now available from Azurity Pharmaceuticals. Brynovin ...
Medscape

International Approvals

International Approvals: Azilect and Lucentis Health Canada has approved rasagiline 0.5- and 1-mg tablets (Azilect), and the Swiss Agency for Therapeutic Products has approved ranibizumab 0.5-mg ...
Business Wire

U.S. Court of Appeals for the Federal Circuit Rules in Favor of Merck in Sitagliptin Dihydrogen Phosphate Patent Lawsuit

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Court of Appeals for the Federal Circuit ruled in favor of the ...
Business Wire

U.S. District Court Rules In Favor of Merck in Sitagliptin Phosphate Patent Lawsuit

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. District Court for the Northern District of West Virginia ruled in ...